Blood sampling as an alternative to tumor biopsies
We’re constantly looking for innovative ways to improve the Springwise experience, and so we’re now introducing BeeLine Reader, a new technology that helps you read more quickly and efficiently. To learn more about BeeLine Reader, an award-winning startup funded by Intel Capital, see BeeLineReader.com.
Pinpointing all the genetic mutations that trigger cancer is a huge Big Data task, and we’ve seen companies use crowdsourcing as a solution, through gamified apps and smartphone computational power. In a potential breakthrough in tumor diagnostics, Guardant Health have developed a blood test alternative to tissue sampling. The team has developed highly sensitive DNA analysis software called Guardant360, which identifies tiny amounts of tumor fragments that enter the bloodstream, mapping specific DNA mutations. The team suggests this method is more reliable than biopsies, as cancerous tumors can be driven by many different DNA mutations that may not be present…
Spotted another good idea???
Join our network and earn rewards